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ABSTRACT 
Background:  The language profile of behavioral variant frontotemporal dementia (bvFTD) 
remains to be fully defined.  
Objective: We aimed to quantify the extent of language deficits in this patient group. 
Methods:  We assessed a cohort of patients with bvFTD (n=24) in relation to patents with semantic 
variant primary progressive aphasia (svPPA; n=14), nonfluent variant primary progressive aphasia 
(nfvPPA; n=18) and healthy age-matched individuals (n=24) cross-sectionally and longitudinally 
using a comprehensive battery of language and general neuropsychological tests. Neuroanatomical 
associations of language performance were assessed using voxel-based morphometry of patients’ 
brain magnetic resonance images. 
Results:  Relative to healthy controls, and after accounting for nonverbal executive performance, 
patients with bvFTD showed deficits of noun and verb naming and single word comprehension, 
diminished spontaneous propositional speech and deterioration in naming performance over time. 
Within the bvFTD group, patients with MAPT mutations had more severe impairments of noun 
naming and single word comprehension than patients with C9orf72 mutations. Overall the bvFTD 
group had less severe language deficits than patients with PPA, but showed a language profile that 
was qualitatively similar to svPPA. Neuroanatomical correlates of naming and word comprehension 
performance in bvFTD were identified predominantly in inferior frontal and antero-inferior 
temporal cortices within the dominant hemispheric language network.  
Conclusions:  bvFTD is associated with a language profile including verbal semantic impairment 
that warrants further evaluation as a novel biomarker. 
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INTRODUCTION 
Among the phenotypes of frontotemporal lobar degeneration, the behavioral variant of 
frontotemporal dementia (bvFTD) is the most clinically, anatomically and pathologically diverse.[1-
5] While patients typically present with social disintegration and personality change,[5,6] there is 
substantial phenotypic overlap with other entities, in particular the primary progressive aphasias 
(PPA), even at relatively early stages.[1,5]. Previous studies including data on language functions in 
bvFTD[6-22] are summarized in Table 1. Deficits in confrontation naming[7,8,9,11,19,22], 
comprehension of single words[7,18] and sentences[6,10,16] and more generalized semantic and 
language impairment[12,14,15,17,20] have been described in bvFTD. Regional frontotemporal 
atrophy in bvFTD often overlaps brain networks canonically concerned with language[2,3] and 
available neuroanatomical evidence has implicated distributed frontal, temporal and parietal 
circuitry in the genesis of language deficits in this syndrome[6,8,9,19]. Taken together, this 
evidence suggests that bvFTD may lead to language dysfunction particularly where there is a 
requirement for processing verbal associations, searching the verbal lexicon or planning 
propositional utterances. However, direct head-to-head comparisons between bvFTD and primary 
progressive aphasia syndromes with simultaneous, comprehensive language assessment and 
neuroanatomical correlation have been undertaken only infrequently[8,9] (see Table 1). Language 
deficits in bvFTD remain incompletely defined and may go unrecognized.  
Here we addressed this issue with a comprehensive assessment of language and general 
neuropsychological functions in a well-characterized cohort of patients with bvFTD. The language 
profile of bvFTD was determined after taking into account general (nonverbal) executive 
performance, an important potentially confounding factor in this group of patients. The bvFTD 
cohort was compared to patient cohorts with canonical syndromic variants of primary progressive 
aphasia, assessed both cross-sectionally and longitudinally, in order to examine the relative salience 
and chart the progression of any language deficits. Neuroanatomical associations of language 
impairments were assessed using voxel-based morphometry of patients’ brain magnetic resonance 
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images. Building on the cumulative evidence of previous work, we hypothesized that patients with 
bvFTD have deficits particularly affecting language functions such as word retrieval and 
propositional speech that are likely to engage executive processes. We further hypothesized that 
these deficits particularly implicate anterior subregions of the distributed dominant hemisphere 
language network.  
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MATERIALS AND METHODS 
Participants 
Twenty-four patients with behavioral variant frontotemporal dementia (bvFTD), 14 patients with 
semantic variant primary progressive aphasia (svPPA) and 18 patients with nonfluent variant 
primary progressive aphasia (nfvPPA) were recruited via a tertiary cognitive disorders clinic as part 
of a cross-sectional and longitudinal cognitive and neuroimaging study of frontotemporal lobar 
degeneration. All patients fulfilled current consensus criteria for a probable or definite syndromic 
diagnosis[1,23] corroborated by general neuropsychological assessment. Genetic screening of the 
patient cohort revealed pathogenic mutations in 11 cases (five C9orf72, four bvFTD, one nfvPPA; 
six MAPT, all bvFTD). Volumetric brain MRI showed compatible profiles of regional brain atrophy 
in each of the syndromic groups; none of the patients had a significant intercurrent burden of 
cerebrovascular disease. Twenty-four healthy individuals with no history of neurological or 
psychiatric illness age-matched to the patient cohort also participated. Demographic, clinical and 
background neuropsychological data for all participant groups are summarized in Table 2. 
All participants gave informed consent, and ethical approval for the study was granted by the 
National Hospital for Neurology and Neurosurgery and the University College London Hospital 
Research Ethics Committees, in line with Declaration of Helsinki guidelines. 
Assessment of language  
Language tests administered to participants covered seven core domains of language processing: 
speech input (an adapted version of the Psycholinguistic Assessment of Language Processing in 
Aphasia subtest 3, PALPA3 minimal pairs discrimination),[24] speech repetition (word and 
sentence repetition),[25] single word comprehension (word – picture matching using the British 
Picture Vocabulary Scale;[26] concrete and abstract words from the synonyms comprehension 
test),[27] sentence comprehension (adapted from the PALPA55 picture-sentence matching 
task),[24] lexical retrieval (noun naming, Graded Naming Test;[28] a novel verb naming test using 
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pictured actions, further details in Supplementary Materials on-line), reading (Graded Nonword 
Reading test,[29] National Adult Reading Test;[30] Schonell Graded Word Reading Test)[31] and 
spelling (Graded Difficulty Spelling test)[32] (see Table 3). Further details of the test procedures are 
provided in Supplementary Material on-line and the language battery used here has been described 
previously [33]. In addition, participants’ spontaneous propositional speech was assessed by asking 
them to describe their last holiday; participants were encouraged to talk for up to three minutes, 
using prompts if necessary. This procedure was designed to be as open-ended as possible, in order 
to compass the anticipated very wide range of fluency and general language competence across 
participant groups; prompts were intended to ensure that the language sample obtained for each 
participant was as complete as possible (examples of prompts included, “Where did you go?”, 
“How long were you there for?”, “How did you get there?”, and “What did you do there?”). Both 
the participants’ responses and any examiner prompts were recorded for offline analysis. 
Longitudinal neuropsychological assessments between one and three years apart were conducted for 
a subset of the bvFTD (n=16; mean (standard deviation) test interval 570 (212) days), svPPA (n=9; 
518 (236) days), nfvPPA (n=10; 409 (110) days) and healthy control (n=15; 471 (190) days) 
groups. The mean test interval did not differ significantly between participant groups. 
Analysis of behavioral data  
Propositional speech recordings were first processed to extract for each participant the total number 
of words, number of words normalized for number of prompts required from the examiner, and 
median word frequency (British National Corpus, spoken portion, http://www.natcorp.ox.ac.uk/). 
The proportions of nouns and verbs produced by each participant were calculated by dividing the 
number of words in each category by total number of words produced, in order to control for overall 
utterance length.  
All behavioral data were analysed using Stata® v12. Demographic characteristics and general 
neuropsychological data were compared between groups using independent samples t-tests for 
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continuous variables and chi square tests for dichotomous variables. Language performance was 
compared between groups separately for each graded difficulty language test and for propositional 
speech variables using a linear regression model incorporating test score as the variable of interest 
with covariates of gender and WASI Matrices score (an index of general nonverbal executive 
function and surrogate of disease severity). In order to take account of near-ceiling performance by 
healthy controls, pass/ fail variables were compared between groups separately using chi-square 
tests. Post hoc subgroup analyses were conducted to compare bvFTD patients with genetic 
mutations with other bvFTD cases using independent samples t-tests for continuous variables and 
chi square tests for dichotomous variables. Neuropsychological performance profiles were 
constructed for each patient group by transforming raw group mean scores on each test to a z-score 
relative to the healthy older control group mean where feasible.  
Longitudinal language data were analysed using Wilcoxon matched-pairs signed-ranks tests. For all 
behavioral comparisons, a threshold of p<0.05 was accepted as the criterion for statistical 
significance.  
Brain image acquisition and analysis 
Volumetric brain MR images were acquired for all patients in a 3.0 T Siemen’s Trio MRI scanner 
using a 32-channel phased array head-coil and a T1-weighted sagittal 3D magnetization rapid 
gradient echo sequence (TE = 2.9msec, TR = 900msec, TI = 2200msec), with dimensions of 256 x 
256 x 208, and voxel size of 1.1 x 1.1 x 1.1 mm3. 
In order to conduct a voxel-based morphometry (VBM) analysis of patients’ neuroanatomical data, 
brain images were first pre-processed and normalized to NMI space using SPM12 software 
(http://www.fil.ion.ucl.ac.uk/spm/software/spm12/) and the DARTEL toolbox with default settings 
for all parameters[34,35] running under Matlab® R2012a. Images were smoothed using a 6mm full-
width at half-maximum (FWHM) Gaussian kernel. To control for individual differences in head 
size, total intracranial volume (TIV) was calculated for each participant by summing grey matter, 
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white matter and cerebrospinal fluid volumes following segmentation. A study-specific template 
brain image was created by warping all native space whole-brain images to the final DARTEL 
template and calculating the average of these images.  
Voxel intensity (an index of brain volume) was modelled separately in each patient group as a 
function of language performance for each task on which bvFTD patients showed a deficit in the 
behavioral analysis. Age, gender, TIV and WASI Matrices score were incorporated as covariates of 
no interest in all models. An explicit brain mask was applied, whereby a voxel was included in the 
analysis if grey matter intensity at that voxel was >0.1 in >70% of the participants.[36] Statistical 
parametric maps (SPMs) were assessed at two significance criteria: thresholded at p<0.05 after 
family-wise error (FWE) correction for multiple voxel-wise comparisons over the whole brain; and 
thresholded at p<0.05FWE after small volume correction within subregions of the left hemisphere 
language network pre-specified in our prior anatomical hypotheses. These anatomical regions 
comprised inferior frontal gyrus, posterior superior temporal cortex and anterior temporal lobe, 
derived from the Juelich Histological and Oxford/Harvard defined brain regions in FSL 
v3.12[37,38] and edited in MRICron® to conform to our customized group template image.[39] 
RESULTS 
Behavioral data 
Results of group comparisons for background neuropsychological tasks are presented in Table 2 
and language tasks in Table 3. Individual raw performance data are presented in Supplementary 
Figure S1 on-line.  
Participant groups did not differ significantly in age, handedness, or educational attainment and 
patient groups did not differ in symptom duration. Males were over-represented in the bvFTD group 
relative to each of the other groups and gender was accordingly incorporated as a covariate of no 
interest in analyses of language variables. Patient groups showed widespread general (extra-
linguistic) neuropsychological deficits and the svPPA and nfvPPA groups showed, as anticipated, 
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specific syndromic language profiles relative to the healthy control group. The bvFTD group 
showed significantly worse recognition memory for words and significantly better verbal and 
nonverbal working memory and arithmetic performance than the nfvPPA group; and significantly 
worse verbal working memory performance than the svPPA group. 
Relative to the healthy control group, the bvFTD group overall showed impairments of noun 
naming, verb naming and concrete single word comprehension (concrete synonyms). Patients with 
bvFTD did not show deficits of abstract single word comprehension, sentence comprehension 
(whether considered overall or separately by PALPA55 grammatical construction categories) or any 
other language domains. The bvFTD group performed significantly better than the svPPA group on 
tests of noun and verb naming, single word comprehension (concrete and abstract synonyms), 
sentence comprehension and spelling; and significantly better than the nfvPPA group on tests of 
nonword repetition and reading. Performance profiles across tests (based on transformed z-scores 
for each of the patient groups relative to the healthy control group) are presented in Figure 1.  
A more detailed analysis of the bvFTD group (summarized in Table S1 in Supplementary Material 
on-line) revealed two subgroups stratified by performance on language tasks: a more severe 
subgroup of 10 patients performing >2 standard deviations below the healthy control group mean 
on tests of both noun naming and single word comprehension and a less severe subgroup 
comprising the remaining 14 bvFTD cases. The more severe subgroup was significantly older, had 
significantly lower MMSE scores and significantly shorter symptom duration than the less severe 
subgroup. However, there were no consistent profiles of regional brain atrophy on MRI for either 
subgroup: both subgroups represented a variety of atrophy profiles and in particular, each subgroup 
contained only a single patient with focal, asymmetric temporal lobe atrophy (see Table S1).   
Post hoc analyses of the genetic subgroups within the bvFTD group (summarized in Table 4) 
revealed that the MAPT mutation subgroup performed significantly worse than the C9orf72 
mutation subgroup on noun naming and single word comprehension (British Picture Vocabulary 
  
10 
 
Scale). The C9orf72 mutation subgroup performed significantly worse than the MAPT mutation 
subgroup on working memory measures (Table 4); no other significant neuropsychological 
differences between the genetic subgroups were identified. 
In the propositional speech analysis, the bvFTD group did not differ from healthy controls in total 
number or mean frequency of words produced but produced significantly fewer words on average 
between prompts than the healthy control group. Median word frequency score in the bvFTD group 
was significantly lower than in both the svPPA and nfvPPA groups. There were no significant 
differences between groups in the proportions of nouns and verbs produced.  
Results of the longitudinal analysis of language data in the participant groups are summarized in 
Table 5. The bvFTD group showed significant deterioration in noun naming between time-points, 
while the nfvPPA group showed a significant interval decline in sentence comprehension and the 
svPPA group showed a significant decline in single word comprehension. The subgroup of bvFTD 
patients less severely affected at baseline showed a longitudinal decline in naming (Table S1), 
indicating this effect was not restricted to more severely affected patients with bvFTD.   
Voxel-based morphometry data 
Neuroanatomical associations with language deficits in the bvFTD group (noun naming and 
concrete single word comprehension) are compared with the svPPA and nfvPPA groups in Table 6; 
statistical parametric maps of associated regional grey matter atrophy in the bvFTD group are 
presented in Figure 2. 
In the bvFTD group, worse noun naming performance was associated with decreased grey matter 
volume in right superior parietal cortex and left anterior fusiform gyrus (p<0.05FWE for multiple 
voxel-wise comparisons over the whole brain), the cluster extending toward the left temporal pole. 
Worse noun naming performance in the nfvPPA group was associated with decreased grey matter in 
left middle temporal gyrus/superior temporal sulcus (p<0.05FWE within pre-specified anatomical 
region of interest); no significant associations between noun naming and grey matter volume were 
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identified in the svPPA group. In the bvFTD group, worse single word comprehension performance 
was associated with decreased grey matter volume in left inferior frontal gyrus and inferior frontal 
sulcus (p<0.05FWE within pre-specified anatomical region of interest, see Figure 2 – though note 
that SPMs are presented at p<0.0001 uncorrected for display purposes); no significant associations 
of single word comprehension were identified in the svPPA or nfvPPA groups. No significant grey 
matter associations of reduced propositional speech output were identified. Reverse contrasts of 
each language variable did not yield significant grey matter associations in any group.    
DISCUSSION 
Here we have shown that language deficits accompany bvFTD even after taking general executive 
performance and disease severity factors into account. These deficits were particularly prominent in 
the domains of single word comprehension (as indexed using the  synonyms test) and lexical 
retrieval (as indexed using the Graded Naming Test). While naming is a multi-component cognitive 
process, the naming deficit demonstrated in the bvFTD group here may be at least partly 
semantically based. The present findings corroborate previous evidence for impairments of naming 
and verbal semantic functions in bvFTD[7,8,9,11,18,19,22] and suggest that a more specific, 
primary verbal semantic deficit may be a core linguistic feature of the bvFTD syndrome. In line 
with this, a profile analysis (Figure 1) revealed a qualitatively similar pattern of deficits in the 
bvFTD and svPPA groups here. While the patient groups were selected according to current 
consensus criteria for the respective syndromes, this resonates with clinical experience and previous 
neuropsychological work suggesting convergence in the behavioral and cognitive profiles of bvFTD 
and svPPA[33,40,41]. It is unlikely the findings are attributable simply to misclassification of 
svPPA cases since the most lexically impaired patients in the bvFTD cohort considered as a 
subgroup did not show a profile of regional brain atrophy compatible with svPPA. It is of interest 
that decline in naming performance over time was a signal of disease evolution in the bvFTD group 
but not in the PPA groups here. While this apparent discrepancy may be at least partly attributable 
to the relatively small size of the present PPA groups and floor effects in the svPPA group, our data 
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suggest that naming as a general index of language function may be a candidate biomarker in 
bvFTD. This is pertinent given the current paucity of biomarkers in bvFTD and the difficulties 
surrounding measurement of the complex social and emotional behaviors that typically dominate 
the clinical picture in this syndrome.  
Neuroanatomical correlates of naming and word comprehension in bvFTD were identified in a 
distributed, predominantly left-lateralized and anterior network of cortical regions, including 
anterior and inferior temporal and inferior frontal cortices. These areas are canonical components of 
the language network and have been previously implicated in word retrieval and control processes 
both in the healthy brain and in lesion studies.[42,43] Similar prefrontal cortical correlates of 
naming performance have been identified in previous work in bvFTD.[9] While the nondominant 
parietal correlate of naming performance shown here appears at first more surprising, strength of 
activation in this region during a semantic decision task has been correlated with off-line naming 
performance in the healthy brain[44] and its engagement here may reflect cross-modal integrative 
mechanisms during the picture naming task or semantic task load in these cognitively impaired 
individuals.[42] It is noteworthy that the bvFTD group also had reduced spontaneous generation of 
propositional language. While a direct neuroanatomical correlate of propositional speech output was 
not identified here, this is likely to be grounded in a similar anterior dominant hemispheric network, 
based on evidence in the healthy brain.[45]  
Differential involvement of these networks may also account for the stratification of language 
profiles between the MAPT and C9orf72 genetic mutation subgroups in this study. Though case 
numbers were not sufficient for direct neuroanatomical correlation, these mutation subgroups have 
been shown previously to have distinct neuroanatomical profiles, with relatively focal involvement 
of anterior temporal and inferior frontal cortices in association with MAPT mutations and 
involvement of a distributed thalamo-cerebello-cortical network in association with C9orf72 
mutations.[4,46] The more severe naming and semantic deficits in the MAPT subgroup compared 
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with the C9orf72 subgroup would be in line with these neuroanatomical signatures and also with 
previously documented cases of patients with MAPT mutations and a clinical phenotype 
overlapping bvFTD and svPPA.[47] 
Taken together, the present findings suggest that involvement of distributed cortical networks 
mediating verbal semantic processing may underpin the language profile of bvFTD and further 
suggest that language impairment may be a relevant clinical issue in these patients. Case numbers in 
this study were relatively small: future work should address language functions prospectively and 
systematically in larger bvFTD cohorts. Like all work of this kind, the present study was potentially 
susceptible to patient floor-performance and healthy control ceiling-performance effects associated 
with conventional neuropsychological tests of language function: this issue will only be fully 
addressed through development of new graded difficulty tests that can capture the very wide range 
of performance across target groups in the relevant language domains.  
It is worth noting that bvFTD represents a diverse clinicopathological spectrum, and there are 
inevitably certain limitations in averaging performances at a group level.[48] It will be of particular 
interest in future work to assess patients with progressive supranuclear palsy and corticobasal 
degeneration who may exhibit prominent verbal adynamia and speech production deficits[49]; and 
patients with defined genetic mutations, as such cases potentially illustrate the molecular phenotype 
of specific brain network disintegration[50].  
The potential role of language indices as biomarkers in bvFTD should be further assessed 
longitudinally over longer periods of follow-up and particularly in genetic mutation carriers at 
presymptomatic and earliest clinical disease stages. The identification of language deficits in 
bvFTD complements previous work delineating behavioral features in PPA syndromes[49] and 
supports the concept of these syndromes as network-based proteinopathies that may transcend 
conventional syndromic boundaries.[5,50]. Our findings underline the potential for substantial 
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syndromic overlap within the frontotemporal lobar degeneration spectrum, with implications for 
current diagnostic formulations.  
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Table 1. Summary of previous studies assessing language functions in behavioral variant frontotemporal dementia  
Study No. of cases, groups Methods Key findings 
 
Cooke et al., 
2003 [6] 
5 bvFTD, 3 nfvPPA, 
11 controls 
Functional MRI of sentence processing bvFTD showed less recruitment of left dorsal inferior frontal cortex 
than controls 
Silveri et al., 
2003 [7] 
17 bvFTD, 42 AD, 34 
controls. 
Tests of object and action naming and 
comprehension 
bvFTD impaired on noun and verb naming and comprehension 
relative to controls  
Grossman et 
al., 2004 [8] 
14 bvFTD, 7 nfvPPA, 
9 CBS, 8 svPPA, 12 
AD, 25 controls 
Tests of confrontation naming, lexical 
retrieval, semantic category judgement;  
voxel based morphometry  
bvFTD impaired on confrontation naming relative to controls.  
Neuroanatomy: naming correlated with grey matter atrophy in left 
anterior cingulate, left parietal, bifrontal, right temporal regions 
McMillan et 
al., 2004 [9] 
14 bvFTD, 8 nfvPPA, 
7 svPPA, 25 controls 
Confrontation naming task; voxel-based  
morphometry  
bvFTD impaired on naming relative to controls.  Neuroanatomy: 
impaired naming correlated with grey matter atrophy in right 
dorsolateral prefrontal cortex 
Grossman et 
al. 2005 [10] 
8 bvFTD, 5 nfvPPA, 3 
svPPA 
Sentence processing tasks bvFTD impaired on sentence comprehension, correlated with 
performance on working memory and executive measures 
Cotelli et al.,  
2006 [11] 
16 bvFTD, 2 nfvPPA, 
10 CBS, 10 PSP, 6 
svPPA, 10 AD, 10 
controls 
Confrontation naming of pictures  bvFTD impaired on naming, actions more impaired than objects  
Blair et al., 
2007 [12] 
20 bvFTD, 54 nfvPPA, 
10 svPPA, 105 AD 
Western Aphasia Battery, administered 
longitudinally 
No differences between bvFTD and AD groups at baseline;  bvFTD 
subsequently impaired on spontaneous speech fluency, sentence 
completion, word recognition 
Cotelli et al., 
2007 [13] 
9 bvFTD, 15 PSP, 
11 CBS, 4 svPPA, 10 
AD, 10 controls 
Tests of violations of semantic coherence, 
grammatical constructions, general language 
tests 
bvFTD not impaired relative to controls  
Murray et al., 
2007 [14] 
8 bvFTD, 6 nfvPPA, 
11 svPPA, 
17 controls 
Assessment of acquisition of grammatical, 
semantic and thematic  associations to a 
novel verb, general neuropsychology tests 
bvFTD impaired in forming verb associations but not impaired on 
grammatical sentence judgement or semantic picture-word matching 
relative to controls 
Peelle et al., 
2007 [15] 
7 bvFTD, 6 nfvPPA, 
20 controls 
Online word-monitoring paradigm to assess 
sentence processing 
bvFTD showed partial sensitivity to grammatical errors but not 
thematic violations 
Peelle et al. 
2008 [16] 
32 bvFTD, 28 nfvPPA, 
28 svPPA, 29 controls 
Sentence comprehension, working memory 
measures; voxel-based morphometry 
Subgroup of bvFTD impaired on comprehension of complex 
sentences. Neuroanatomy: no correlation with sentence 
comprehension in bvFTD 
Garcin et al.,  
2009 [17] 
91 bvFTD  Survival analysis of bvFTD patients with 
data on clinical features at presentation 
Semantic deficits, word-finding difficulty and general language 
impairment associated with shorter survival in bvFTD 
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Gunawardena 
et al., 2010 
[18] 
12 bvFTD, 16 nfvPPA, 
13 controls 
Semi-structured speech and 
neuropsychological measures of executive 
functioning and language; cortical thickness  
bvFTD produced less words per minute (WPM) than controls, and 
significantly impaired on semantic comprehension but not 
confrontation naming, relative to controls. Neuroanatomy: bvFTD 
showed more anterior cortical thinning (including significant medial 
frontal thinning) than nfvPPA. No relationships observed between 
reduced WPM and cortical thinning 
Hughes et al., 
2011 [19] 
12 bvFTD, 16 controls General neuropsychology tests; categorical 
semantic judgements during 
magnetoencephalography 
bvFTD impaired on naming and semantic decisions.  Neuroanatomy: 
reduced activity of left frontoparietal network correlated with 
measures of semantic association 
Hsieh et al., 
2012 [20] 
8 bvFTD, 8 svPPA, 12 
AD, 15 controls 
Tests of emotion word, abstract and concrete 
non-emotion word comprehension 
bvFTD impaired relative to controls and svPPA on emotion word 
associations only 
Kaiser et al., 
2013 [21] 
11 bvFTD, 
10 AD 
Tests of proverb interpretation, other 
executive and semantic tests; tensor-based 
morphometry  
bvFTD impaired on proverb interpretation relative to AD, correlating 
with semantic measures. Neuroanatomy: impaired proverb 
interpretation correlated with L > R anterior temporal lobe atrophy 
Roca et al., 
2013 [22] 
35 bvFTD, 14 controls Tests of executive functions, confrontation 
naming, semantic knowledge 
More severe deficits in ‘low-functioning’ bvFTD subgroup, 
particularly affecting confrontation naming  
 
Key: AD, Alzheimer’s disease; bvFTD, behavioral variant frontotemporal dementia; CBS, corticobsasal syndrome; nfvPPA, nonfluent variant of 
primary progressive aphasia; PSP, progressive supranuclear palsy; svPPA, semantic variant of primary progressive aphasian applied) (current 
diagnostic classifications have been applied). 
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Table 2. Demographic and general cognitive characteristics of participant groups. 
Characteristic   Controls svPPA nfvPPA bvFTD 
Demographics 
     
No. (male:female) 
 
24 (9:15) 14 (7:7)* 18 (14:4)* 24 (20:4) 
Handedness (R:L) 
 
13:3 12:2 18:0 20:4 
Age (years) 
 
63.8 (7.8) 66.0 (6.7) 68.5 (9.0) 64.6 (7.7) 
Education (years) 
 
15.3 (2.9) 13.6 (3.2) 13.8 (3.1) 14.8 (3.8) 
Symptom duration (years) NA 6.7 (4.1) 5.7 (5.2) 7.8 (5.2) 
General cognitive functions 
  
MMSE (/30) 
 
30 (0.6) 21 (6.5) 23 (8.7) 24 (5.7) 
WASI Verbal IQ 120 (7) 71 (18)* 73 (13)* 83 (22) 
 
Performance IQ 116 (9)  101 (19) 92 (17) 93 (21) 
Stroop Color naming (seconds) 30 (4.9) 52 (24.5)* 70 (17.8)*† 40 (15.3) 
 
Word reading (seconds) 22 (2.8) 31 (11.5) 58 (20.7)*† 28 (15) 
 
Response suppression (seconds) 57 (12.9) 98 (46.7) 135 (48)*† 88 (38.4) 
Episodic memory RMT Faces (/50) 43 (4.6) 34 (8) 36 (6.3) 33 (6.9) 
 
RMT Words (/50) 48 (2.3) 33 (7.3)‡ 41 (6.7) 35 (7.5) 
Working memory DS forward 7 (0.9) 6.5 (1.3) 4.7 (1.3) *† 6.3 (1.5) 
 
DS reverse 5.1 (0.9) 4.9 (1.5) 2.5 (1.6) *† 4.1 (1.8) 
SS forward 5.3 (0.9) 4.6 (1.2) 4 (1) * 5 (1.5) 
 
SS reverse 5.5 (0.8) 4.5 (1.2) 3.4 (1.5) *† 4.3 (1.5) 
Arithmetic GDA (/24) 15 (4.3) 8.4 (8.2) 4.1 (2.9)*† 9.9 (7.1) 
Mean (standard deviation) values are presented and for neuropsychological tests the maximum 
score is indicated in parentheses, unless otherwise indicated. Significant differences (p<0.05) from 
healthy control values are in bold; *significantly different (p<0.05) from bvFTD group; 
†significantly different (p<0.05) from svPPA group; ‡significantly different (p<0.05) from 
nfvPPA group. bvFTD, behavioral variant frontotemporal dementia; DS, Digit Span; GDA, 
Graded Difficulty Arithmetic test; MMSE, Mini-Mental State Examination; nfvPPA, nonfluent 
variant primary progressive aphasia; RMT, Recognition Memory Test; SS, Spatial Span; svPPA, 
semantic variant primary progressive aphasia; WASI, Wechsler Abbreviated Scale of Intelligence. 
Details of numbers of participants in each group completing each test are provided in 
Supplementary Material on-line. 
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Table 3. Language characteristics of participant groups. 
Characteristic   Controls svPPA nfvPPA bvFTD 
Language 
     
Pass/ fail tests 
     
Auditory input PALPA3 (≥34/36)a 96% 83% 50% 77% 
Word retrieval Verb naming (24/24) 100% 0%* 24%* 64% 
Repetition Polysyllabic words (≥38/45) 96% 92% 18%*† 86% 
 
Sentences (10/10) 92% 62% 20%*† 83% 
Reading Nonwords (≥23/25) 96% 64% 25%*† 64% 
Graded difficulty tests 
    
Comprehension: 
Single words  
BPVS (/150)b 147 (2.5) 72 (50.8)*‡ 126 (34.1) 123 (33.5) 
Synonyms: Concrete (/25)a 24 (1.2) 13 (6)*‡ 21 (3.6) 19 (4.7) 
 
Synonyms: Abstract (/25)a 24 (1.8) 14 (5)*‡ 20 (4.6) 20 (5) 
Sentences PALPA55 (/24)c 23 (1.2) 20 (5.1)* 19 (4.5) 22 (3.1) 
Word retrieval GNT (/30) 26 (3.5) 0.3 (0.6)*‡ 11 (9.9) 11 (8.3) 
Reading NART/ Schonell (IQ) 122 (4) 92 (21)* 90 (27)* 105 (19) 
Spelling GST (/30) 26 (2.6) 11 (9.1)* 14 (9.6) 18 (10) 
Propositional speech¶ 
    
 
total words 250 (131) 227 (148) 69 (56) 183 (118) 
 
total nouns/total words 0.14 (0.04) 0.13 (0.04) 0.16 (0.07) 0.14 (0.03) 
 
total verbs/total words 0.16 (0.03) 0.21 (0.03) 0.18 (0.08) 0.18 (0.03) 
 
mean words/prompt§ 238 (144) 75 (56) 27 (36) 79 (50) 
 
median word frequency¶ 31 (4.5) 45 (9.8)* 46 (4.6)* 36 (13.6) 
Mean (standard deviation) scores are presented and the maximum score is indicated in parentheses, 
unless otherwise indicated. For variables that healthy control subjects are expected to score at or 
near ceiling, values represent percentages of people in each group scoring at or above the minimum 
score anticipated for a healthy control (given in parentheses). Significant differences (p<0.05) from 
healthy control values are in bold; *significantly different (p<0.05) from bvFTD group; 
†significantly different (p<0.05) from svPPA group; ‡significantly different (p<0.05) from nfvPPA 
group. §total number of words produced / number of prompts from experimenter; ¶all values x103; 
a, chance-level performance 50%; b, chance-level performance 25%; c, chance-level performance 
33%; BPVS, British Picture Vocabulary Scale; bvFTD, behavioral variant frontotemporal dementia; 
GNT, Graded Naming Test; GST, Graded Difficulty Spelling test; NART, National Adult Reading 
Test; nfvPPA, nonfluent variant primary progressive aphasia; PALPA, Psycholinguistic Assessment 
of Language Performance in Aphasia; svPPA, semantic variant primary progressive aphasia. Details 
of numbers of participants in each group completing each test are provided in Supplementary 
Material on-line. 
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Table 4. Characteristics of genetic subgroups with behavioral variant frontotemporal dementia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are presented for patient subgroups with defined mutations in the MAPT or C9orf72 
genes. Mean (standard deviation) values and raw scores for neuropsychological tests are 
presented unless otherwise indicated; maximum scores are indicated in parentheses. For 
variables that healthy control subjects are expected to score at or near ceiling, values represent 
percentages of people in each group scoring at or above at or above the minimum score 
anticipated for a healthy control (given in parentheses). Significant differences (p<0.05) for 
each generic subgroup compared with healthy control values are in bold; *significantly worse 
than other genetic subgroup (p<0.05). a, chance-level performance 50%; b, chance-level 
performance 25%; c, chance-level performance 33%; BPVS, British Picture Vocabulary Scale; 
DS, Digit Span; GDA, Graded Difficulty Arithmetic test; GNT, Graded Naming Test; GST, 
Graded Difficulty Spelling test; MMSE, Mini-Mental State Examination; NART, National 
Adult Reading Test; PALPA, Psycholinguistic Assessment of Language Performance in 
Aphasia; RMT, Recognition Memory Test; SS, Spatial Span; WASI, Wechsler Abbreviated 
Scale of Intelligence.  
Characteristic MAPT C9orf72 
Demographics   
No. (male:female) 
4:2 
3: 
1 
Handedness (R:L) 6:0 4:0 
Age (years) 61.5 (3.9)* 67.5 (3.1) 
Education (years) 16.3 (4.4) 14.8 (4.1) 
Symptom duration (years) 8.7 (5.9) 9.8 (7) 
General cognitive    
MMSE (/30)  25 (5) 25 (4.7) 
WASI Verbal IQ 83 (19.7) 84 (20.6) 
Performance IQ  98 (10.3) 88 (27) 
Episodic 
memory 
RMT Faces  33 (10.4) 33 (6.4) 
RMT Words  30 (6.7)* 39 (2.4) 
Working 
memory 
DS forward  7 (0.9) 5.3 (0.5)* 
DS reverse  5 (1.4) 4 (0.8) 
SS forward  5.8 (0.8) 4.3 (1.5)* 
SS reverse  5 (0.9) 4.3 (1.5) 
Arithmetic GDA (/24) 11 (5.1) 9.8 (8.3) 
Language skills     
Pass/fail variables   
Auditory input PALPA3 (≥34/36)a 83% 100% 
Repetition Polysyllabic words (≥38/45) 100% 100% 
Word retrieval Verb naming (20/20) 67% 75% 
Reading Nonwords (≥23/25) 50% 75% 
Graded difficulty tests 
Comprehension: 
Single words 
BPVS (/150)b 120 (24)* 141 (6.6) 
Synonyms: Concrete (/25)a 20 (5.5) 22 (2.1) 
Synonyms: Abstract (/25)a 20 (4.5) 22 (2.1) 
Sentences PALPA55 (/24)c 23 (0.5) 22 (2.4) 
Word retrieval GNT (/30) 5 (6)* 20 (4.6) 
Reading NART/Schonell (IQ) 105 (19.7) 111 (8.7) 
Spelling GST (/30) 14 (10.9)  24 (0) 
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Table 5.  Longitudinal comparisons of language performance in participant groups 
Characteristic  Time-point Controls svPPA nfvPPA bvFTD 
Inter-test interval (days) - 471 (190) 518 (236) 409 (110) 570 (212) 
BPVS (/150) 1 148 (1.2) 87 (47.8) 143 (4.9 128 (28.6) 
 2 147 (2.2) 67 (50.1) 131 (27.9) 132 (16.2) 
Concrete synonyms (/25) 1 24 (0.7) 14 (7.6) 21 (1.8) 21 (2.8) 
 
2 24 (0.8) 15 (3.7) 21 (2.6) 21 (4.2) 
Abstract synonyms (/25) 1 24 (0.9) 17 (5.8) 20 (3.7) 22 (4.7) 
 
2 24 (0.8) 15 (3.7) 19 (4.8) 22 (2.4) 
PALPA 55 (/24) 1 24 (0.8) 22 (3.4) 21 (2.5) 22 (1.9) 
 
2 24 (0.7) 22 (2.3) 17 (6.3) 22 (1.5) 
GNT (/30) 1 26 (3.6) 0.4 (0.7) 18 (6.6) 13 (8.4) 
 2 26 (3.6) 0 (0) 12 (10.1) 10 (8.3) 
Values denote mean (standard deviation) raw scores for neuropsychological tests unless 
otherwise indicated; maximum scores are indicated in parentheses. Significant differences 
(p<0.05) between time-points within patient groups are indicated in bold. Details of numbers of 
participants in each group completing each test are provided in Supplementary Material on-
line. BPVS, British Picture Vocabulary Scale; GNT, Graded Naming Test; PALPA, 
Psycholinguistic Assessment of Language Performance in Aphasia. 
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Table 6. Neuroanatomical associations of language deficits in patient groups  
Language test Brain region Side Cluster size Peak (mm) Z score P value 
     (voxels) x y z     
bvFTD         
GNT Superior parietal lobe R 162 27 -60 46 5.22* 0.01 
 
Anterior fusiform gyrus L 5662 -34 -12 -42 5.13* 0.014 
Synonyms Inferior frontal gyrus / sulcus L 146 -44 46 9 4.43 0.011 
         
nfvPPA         
GNT 
Middle temporal gyrus/ 
superior temporal sulcus 
L 829 -50 -56 8 4.62 0.005 
 
The table shows grey matter associations identified in the voxel-based morphometric analysis of 
language test performance in the patient cohort. All clusters greater than 100 voxels in size are 
shown with coordinates of local maxima in MNI space; *significant at p<0.05FWE after multiple 
comparisons over whole brain; other associations significant at p<0.05FWE after multiple 
corrections within the pre-specified region of interest (see text). bvFTD, behavioral variant 
frontotemporal dementia; GNT, Graded Naming Test (nouns); nfvPPA, nonfluent variant primary 
progressive aphasia; Synonyms, test of single word comprehension (see text and Supplementary 
Materials for details). 
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Figures 
 
Figure 1. Neuropsychological profiles of patient groups relative to the present healthy older control 
group. The profiles incorporate tests for which raw scores have been transformed so that 0 
represents the mean score of the healthy control group; larger deviations from this thus indicate 
increasing impairment relative to controls. Error bars represent ± 1 standard error of the mean. Abs, 
abstract synonyms; Arit, arithmetic; bvFTD, behavioral variant frontotemporal dementia; Conc, 
concrete synonyms; DSF/R, Digit Span Forward/ Reverse; GDA, Graded Difficulty Arithmetic test; 
GNT, Graded Naming Test; GST, Graded Difficulty Spelling test; nfvPPA, nonfluent variant 
primary progressive aphasia; P-55, Psycholinguistic Assessment of Language Performance in 
Aphasia; RMTF/W, Recognition Memory Test for faces/words; SSF/R, Spatial Span Forward/ 
Reverse; svPPA, semantic variant primary progressive aphasia. See text for details. 
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Figure 2. Statistical parametric maps (SPMs) of regional grey matter loss associated with 
impaired performance on tests of word retrieval (Graded Naming Test, above) and single 
word comprehension (concrete synonyms test, below) in the patient group with behavioral 
variant frontotemporal dementia are shown. SPMs are thresholded at p < 0.001 uncorrected 
for display purposes (all associations significant at p<0.05FWE for multiple corrections over the 
whole brain or within the prespecified anatomical region of interest, see Table 2), and 
displayed on sections of the mean normalized T1-weighted structural brain MR image; the left 
hemisphere is presented on the left in the axial section and MNI coordinates for the plane of 
each section are indicated. The color bar codes the range of Z-scores for each SPM.  
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SUPPLEMENTARY MATERIAL 
The language profile of behavioral variant frontotemporal dementia,  
by CJ Hardy et al 
Details of language test procedures 
Speech input processing was assessed using the Psycholinguistic Assessments of Language 
Processing in Aphasia Test 3 (PALPA3)[24] word minimal pairs discrimination test (36 trials): this 
test of phoneme perception required participants to decide whether pairs of spoken monosyllabic 
words are the same (e.g. ‘cat’ – ‘cat’) or different  (e.g. ‘cat’ – ‘tack’). 
Speech repetition was assessed using the polysyllabic word repetition task[25] (45 trials) 
comprising single words of one, two and three syllables in length. The subject was required to 
repeat the word (e.g. skeleton) back to the examiner verbatim. 
Single word comprehension was assessed using concrete nouns and abstract words from the 
synonyms comprehension test[27] (25 trials in each noun category): on each trial participants were 
required to judge which of two response words (presented both spoken and written) most closely 
matched the probe word (e.g. for concrete, chapel: altar/ church? for abstract, macabre: ugly/ 
gruesome?) 
Sentence comprehension was assessed using the PALPA55[24] picture-sentence matching task (24 
trials): on each trial participants were shown three pictures of a scenario and required to identify 
which picture matched a verbal sentence description.  
Noun naming was assessed using the Graded Naming Test (GNT)[28] (30 trials): in this picture 
naming task items of graded difficulty were presented, ranging from highly familiar (e.g. 
‘kangaroo’) to relatively unfamiliar (e.g. ‘sextant’).  
Reading was assessed using the Graded Nonword Reading test[31] (25 trials): participants were 
presented with nonwords of graded difficulty from one syllable to three syllables in length. Word 
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reading was assessed with the National Adult Reading Test (NART)18. The Schonell Graded Word 
Reading Test19 was also administered if participants scored <15 on the NART. 
Spelling was assessed using the Graded Difficulty Spelling test[32] (30 trials): participants were 
presented with trials of graded difficulty each comprising the target word, followed by its use in a 
sentence, followed by the target word again (e.g., “Said. I said I would come. Said.”). 
Verb naming was assessed using a task developed in-house, in which participants were shown 
picture of actions (e.g., a man running) and asked to name the verb (20 trials; see example below). 
Healthy subjects are expected to perform at ceiling on this task. 
Task instruction: “I have a set of pictures here, in each one I would like you to tell me what the 
person is doing. They are all –ing words”.  
E.g. “Smelling” 
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Table S1. Data for subgroups of more and less severely affected bvFTD patients 
Characteristic More severe Less severe 
No. 10 14 
Age (years) 60 (4.6) 68 (8.2) 
Symptom duration (years) 9 (4.6) 6.9 (5.6) 
Brain MRI atrophy profile   
   Focal left temporal 1 0 
   Focal right temporal 0 1 
   Bilateral temporal 3 5 
   Bilateral frontal 4 3 
   Right > left frontotemporal 0 3 
   Bilateral frontotemporal 2 2 
MMSE (/30) 19.7 (5.3) 27.4 (3.2) 
GNT (/30) 6.3 (6.8) 14.7 (7.5) 
   Time-point 1 7.3 (8) 14.7 (8) 
   Time-point 2 7.8 (9)a 11.3 (8)*b 
Synonyms: Concrete (/25) 14.3 (3.7) 22.4 (1.3) 
 
‘More severe’ is here defined as those patients performing >2 standard 
deviations below the healthy control group mean on tests of naming and 
single word comprehension. Mean (standard deviation) values are 
presented unless otherwise indicated. an=4; bn=12. GNT, Graded Naming 
Test; MMSE, Mini-Mental State Examination Score. Significant 
differences between subgroups are indicated in bold; *significant 
difference between time-points.  
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Participant numbers 
Numbers of participants in each group completing each of the tests listed in Tables 2 to 5 were 
as follows:   
Table 2 
Healthy controls: MMSE (16), GST (23), GDA (23), SS forward (23), SS reverse (23) 
Handedness information also only available for a subset (16).  
svPPA: Stroop color naming (12), Stroop word reading (13), Stroop response suppression 
(12), RMT Faces (13), RMT Words (13).  
nfvPPA: Stroop color naming (12), Stroop word reading (13), Stroop response suppression 
(10), RMT faces (17), DS forward, DS reverse, SS forward, SS reverse (all 17), NART/ 
Schonell (16), nonword reading (16), GST (16), GDA (14).  
bvFTD: Stroop color naming (22), Stroop word reading (22), Stroop response suppression 
(20), RMT faces (22), RMT words (21), SS forward (21), SS reverse (21), nonword reading 
(22), GST (22). 
Table 3 
Healthy controls: Propositional speech (15). 
svPPA: PALPA3 (12), word repetition (13), Synonyms concrete (12), Synonyms abstract (12), 
Propositional speech (4) 
nfvPPA: PALPA3 (16), Verb naming (16), word repetition (17), sentence repetition (13), 
Synonyms concrete (17), Synonyms abstract (22), PALPA55 (22), Propositional speech (7). 
bvFTD: PALPA3 (22), word repetition (21), sentence repetition (23), Synonyms concrete 
(23), Synonyms abstract (22), PALPA55 (21), Propositional speech (9). 
Table 4 
MAPT: RMT faces (5), RMT words (5), Synonyms concrete (5), Synonyms abstract (5), 
PALPA55 (5). 
C9orf72: SS forward (3), SS reverse (3), GST (3), PALPA 3 (3), Word repetition (2). 
Table 5 
Healthy controls: GNT (15), Synonyms concrete (12), Synonyms abstract (13), PALPA 55 
(12), BPVS (13). 
svPPA: GNT (9); Synonyms concrete (5); Synonyms abstract (5); PALPA 55 (6); BPVS (9). 
nfvPPA: GNT (8); Synonyms concrete (10); Synonyms abstract (10); PALPA 55 (9); BPVS (10). 
bvFTD: GNT (16); Synonyms concrete (11); Synonyms abstract (12); PALPA 55 (8); BPVS (16). 
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Figure S1. Individual raw performance data on language tests are plotted for each participant group; y-axes show test scores (note change of 
scale between tests). BPVS, British Picture Vocabulary Scale; bv, behavioral variant frontotemporal dementia; GNT, Graded Naming Test; GST, 
Graded Spelling Test; HC, healthy controls; nv, nonfluent variant of primary progressive aphasia; PALPA, Psycholinguistic Assessment of 
Language Processing in Aphasia (PALPA3, minimal pairs discrimination; PALPA55, sentence comprehension); Reading, nonword reading; sv, 
semantic variant of primary primary progressive aphasia; Synonyms, concrete noun comprehension (data for abstract nouns not shown). See text 
for further details. 
 
